Dyne Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States201-500 Employees
Dyne Therapeutics is a clinical-stage biotechnology company based in Waltham, Massachusetts, focused on delivering functional improvement for people with genetically driven neuromuscular diseases. It develops therapies aimed at skeletal muscle and the central nervous system to address underlying disease causes and improve function. The company is advancing clinical programs for Duchenne muscular dystrophy and myotonic dystrophy type 1, with preclinical work targeting facioscapulohumeral muscular dystrophy and Pompe disease. Its work centers on translating scientific discoveries into treatment options that impact patients, families and communities. Dyne serves patients and their families within the biotechnology research sphere, pursuing solutions for unmet medical needs in neuromuscular diseases. In 2026, the company announced preclinical data supporting the FORCE platform's ability to cross the blood-brain barrier and reduce MAPT RNA in the central nervous system, with results to be presented at the ASGCT 2026 Annual Meeting.